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The effect of N-terminal diproline segment and charged side chains on the stabilization of 
helical conformation in alanine-based short peptides are examined using molecular dynamics 
(MD) simulations. The cationic peptides, Ac–Pro1–Pro2–Ala3–Lys4–Ala5–Lys6–Ala7–Lys8–
Ala9–NH2 (Ia) and Ac–
D
Pro1–Pro2–Ala3–Lys4–Ala5–Lys6–Ala7–Lys8–Ala9–NH2 (IIa) are 
examined for the role of lysine side chains on the inducement of helical conformation in 
alanine-based short peptides. To examine the influence of lysine and glutamic acid in the i, i 
+ 4 arrangement on the stabilization of helical conformation, cationic peptides, Ia and IIa, 
are modified as ion-pair peptides, Ac–Pro1–Pro2–Glu3–Glu4–Ala5–Ala6–Lys7–Lys8–Ala9–
NH2 (Ib) and Ac–
D
Pro1–Pro2–Glu3–Glu4–Ala5–Ala6–Lys7–Lys8–Ala9–NH2 (IIb), 
respectively. MD simulations manifest enhanced occupancies in the basin of φψspace for 
ion-pair peptides as compare to cationic peptides. The radial distribution function (RDF) 
analysis highlight that large side chain substituents of lysine and glutamic acid assist in helix 
formation by blocking water molecules from solvating backbone CO and NH groups.  
  




The native state of proteins is stabilized by a complex interplay of hydrophobic effect, van 
der Waals forces, hydrogen bonding, electrostatic contribution of salt bridges, and helix-
dipole interactions, however, relative contribution of these interactions remains unclear. The 
elucidation of quantitative contribution of these interactions remains a formidable challenge 
given the size of a typical protein and the complexity of its interactions.
[1]
 To illuminate the 
underlying principles that govern stabilization of the native state of proteins, bottom-up 
approach of simple to incrementally complex models have been adopted. The alanine-based 
short peptides have been utilized to analyze the conformational preferences of the 
polypeptide chain and addressing the basis using computer simulations.
[2]
 The empirical force 
fields have been applied for simulation of equilibria to address the thermodynamics with 
rigor.
[3]
 During last years, alanine-based short peptides are emerged as the protein main chain 
models to elucidate the underlying fundamental forces that govern protein folding-unfolding 
equilibrium.
[4]
 The models highlighted that unfolded proteins adopt appreciable order as 
semi-extended structures in correspondence of PPII conformation.
[4h-4j,4l,4n,4o]
 
The α-helix is one of the most important structural domains in proteins and peptides that 
control numerous biological activities and functions.
[5]
 The studies focused on the 
enhancement of overall helicity and stability of short helical peptides have contributed to the 
fundamental understanding of protein folding-unfolding equilibrium and have led to 
improvement in the biological and pharmaceutical activities.
[6]
 The use of short synthetic 
peptides encompassing helical segments to modulate protein-protein interactions (PPIs) 
associated with human diseases represent great pharmacological interest. The majority of the 
PPIs involves -helices, and has large interaction areas and shallow surfaces; thus, small 
molecule inhibitors are not effective for modulating PPIs.
[7]
 During last years, constrained 
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peptides have been developed for modulating PPIs by enhancing the helicity of short 
peptides.
[8]
 Thus, a better understanding of the α-helix structure and elucidation of factors that 
dictate its structure is of key importance.  
The role of non-covalent interactions and their effects in folding and stability of -helix and 
-sheet peptides have been highlighted in literature.
[9]
 The electrostatic interactions among 
main chain, side chains are well recognized for their role in promoting conformational 
folding in polypeptide structure.
[10] 
The folding simulations of all-alanine peptides and a 
number of short alanine-based helical peptides with positively or negatively charged residues 
have highlighted the role of hydrophobic interaction and charged side chains in the folding of 
-helical peptides.
[9a,9e,9f,9i]
 In addition, computer simulations of these short helical alanine-
based peptides and the peptides with salt bridge pairs have provided deeper insights into the 
role of charged side chains in the stability of helical peptides.
[2e,9g]
 Meuzelaar et al. have 
investigated the effect of salt bridges between different types of charged amino-acid residue 
pairs on -helix folding using a combination of ultraviolet circular dichroism, temperature-
jump transient-infrared spectroscopy, and molecular dynamics simulations.
[11]
 The authors 
highlighted that stabilizing salt bridges speed up -helix formation by up to 50% and slow 
down the unfolding of the -helix, whereas salt bridges with an unfavorable geometry have 
the opposite effect. Walker et al. highlighted the contribution of arginine-glutamate salt 
bridges to the helix stability of the peptide with the sequence 
AAARAAAAEAAEAAAARA.
[12]
 The present study aim to exploit N-terminal diproline of 
homochiral and heterochiral structure, and charge-group effect over side chains to assess the 
role of specific structure modification planned in conformational equilibria of the model 
peptides.   
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The effect of N-terminal residue stereochemical mutation from L- to D-structure and chain-
length have been addressed with molecular dynamics for the possibility of inducement of 
helical conformation in the oligoalanine models.
[13]
 MD simulations reveal promotion of 
small fraction of helical conformation in oligoalanine models that involve specific effect of 
stereochemical modification in the N-terminal residue and chain-length. The role of 
stereochemical modification of amino acid residue from L- to D-structure in delineation of 
protein folding mechanism,
 [14]
 to increase the stability of proteins,
[15]
 in the redesign an 
active and specific ion channel,
 [16]
 and in the design of novel folds is reported.
[17]
 The present 
study address the alanine-based nonapeptide of poly-L structure for the stereochemical effect 
in N-terminal residue and charge-group effect over side chains that are capable of ordering 
the peptide as a helical fold. The model peptides are examined with molecular dynamics 
(MD) to assess the possible contribution of extended-, semi-extended PPII and helical 
conformations in the equilibrium ensemble. The implications for understanding of the 
inducement of helical conformation in alanine-based short peptides are discussed. The results 
of the present study will aid in the design of novel peptides with helical structures. The role 
of helical structures in the rational design of biocompatible hydrogels and inhibition of 
disease-relevant intracellular or extracellular PPIs is a topic of current research.
[18]
   
Results and discussion 
The study is implemented with nine-residue length peptides (Table 1). The models are 
primarily alanine-based short peptides, and thus the sequences of an intrinsically helix 
favoring residue. The model alanine-based short peptide is substituted with internal charged 
side chains, Lys and Glu residues, to promote helical fold.  The model peptides are equipped 
with diproline segment of homochiral and heterochiral structure for possible inducement of 
helical conformation. The diproline segments have been reported as potential nuclei for 
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initiating helical folding in peptides.
[19]
 Kemp et al. have highlighted that covalently 
constrained diproline surrogate as the effective template for inducing helical conformations in 
short acyclic sequences.
[20] 
Thus, a combination of N-terminal diproline of homochiral, 
heterochiral structure and charge-group effect over side chains is examined for possible 
inducement of helical folds. The cationic peptides, Ia and IIa, are designed to assess the 
effect of N-terminal diproline of homochiral and heterochiral structure, respectively, and the 
role of lysine side chains for the inducement of helical conformation. The ion-pair peptides, 
Ib and IIb, with N-terminal diproline of homochiral and heterochiral structure, respectively, 
are designed to assess the influence of large side chain substituents of lysine and glutamic 
acid residues in the i, i + 4 arrangement on the nucleation of helical conformation. 
Table 1. The end-protected cationic peptides, Ia and IIa, and ion-pair peptides, Ib and IIb chosen for molecular 
dynamics. The peptides Ia and Ib have N-terminal homochiral diproline segment while peptides IIa and IIb 
have N-terminal heterochiral diproline segment for the inducement of helical conformation.  









The molecular dynamics ensembles were prepared with GROMOS96 43a1 force field as 
described in the computational section. The GROMOS force field was adopted for the present 
study as it has been widely used for the conformational analysis of peptides.
[21]
 Best et al. 
have reported large deviations with the experimental data in the computational studies of 
(AAQAA)3 peptide using replica exchange simulations with CHARMM22/CMAP, 
AMBER99SB, and AMBER03 force fields.
[3d] 
CHARMM22/CMAP and AMBER03 
overstabilized the helix i.e. 95% and 87% helix at 300 K, respectively, whereas 
AMBER99SB understabilized the helix i.e. 2% at 300 K. Relative to experimental 
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measurements, the α-helical propensity of AMBER03 force field
[22]
 is too high, while α-
helical propensity is too low for AMBER99SB.
[3g,23]
 The OPLS force field was regarded as 
the best force field in the description of the microstructures of organic molecules (i.e. liquid 
benzene).
[24]
  Gerben et al. have compared the popular atomistic force fields, AMBER03, 
CHARMM22 + CMAP, GROMOS96, and OPLS-AA, to examine the force field that yield 
results in accordance with the experimental results using Aβ peptide.
[25]
 The authors 
highlighted that AMBER03 and CHARMM22 + CMAP over-stabilize helical structure 
within Aβ by comparing secondary structure content, NMR shifts, and radius-of-gyration (Rg) 
to available experimental data. On the other hand, OPLS-AA and GROMOS96 yield helical 
and β-strand content, calculated NMR shifts, and radius-of-gyration that agree well with 
experimental data.   
The model peptides were submitted to molecular dynamics for long enough duration to 
achieve equilibrium. For assessment of attainment of equilibrium, MD trajectories were 
evaluated for time dependent evolution in microstates of the polypeptide structure. This 
enumeration was approached with clustering algorithm of Daura et al.
[26] 
The polypeptide 
structures populating MD trajectory were clustered in Cartesian space with root-mean-square 
deviation (RMSD) cutoff ≤ 0.15 nm over backbone atoms (N, C, C, C), giving microstates 
diminishing in population, viz., diminishing thermodynamic stability. The molecular 
dynamics ensembles were assessed in radius-of-gyration (Rg) over populated conformers. In 
addition to Rg, the ensembles were assessed in the occupancy of specific φψ basins, and in 
the main-chain hydrogen bonds that are short-ranged (SR; i→i ± 2), medium-ranged (MR; 
i→i ± 3; i→i ± 4), and long-ranged (LR; i→i ± 5; i→i ± ≥ 6) according to sequence 
separation between donor and acceptor residue.  
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The time dependent evolution of MD trajectories in microstates of polypeptide structure is 
shown in Figure 1. The ion-pair peptides, Ib and IIb, are noted to achieve equilibrium early 
and saturate to a defined population in microstates. The cationic peptides, Ia and IIa, are 
noted to evolve more slowly and do not attain robust asymptote over the observation time of 
250 ns. Assuming reasonable approximation of equilibria, simulations were terminated at the 
time points noted in Figure 1 and the ensembles were compared as macrostates and over the 
microstates. As noted in Table 2, the ion-pair peptides, Ib and IIb, populate in much smaller 
number of microstates, 280 and 219, respectively, compare to cationic peptides, Ia and IIa, 
564 and 590, respectively. Correspondingly, the population of most-populated microstate 
increased from 14.8% and 14.5% for Ia and IIa, respectively, to 16.9% and 23.3% for Ib and 
IIb, respectively. Thus, conformational ensemble is less heterogenous for ion-pair peptides, 
Ib and IIb, as compare to cationic peptides, Ia and IIa. Thus, a combined effect of N-
terminal diproline of homochiral, heterochiral structure and large side chain substituents of 
lysine and glutamic acid residues in the i, i + 4 arrangement reduce the conformational 
diversity in ion-pair peptides, Ib and IIb. 
 
Figure 1. The evolution of microstates over end-protected cationic peptides, Ia and IIa, and ion-pair peptides, 
Ib and IIb, during molecular dynamics in water as explicit-solvent. Y-axis represent the number of microstates 
and X-axis represent molecular dynamics simulation time in ns.  
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Ia 564 14.8 0.56  0.13 0.46  0.02 19.2 25.9 44.3 1.1 0.28 0.46 0.33 
Ib 280 16.9 0.52  0.08 0.49  0.02 28.5 23.4 39.2 1.2 0.17 0.70 0.32 
IIa 590 14.5 0.52  0.10 0.47  0.02 19.9 25.4 45.1 1.2 0.27 0.53 0.44 
IIb 219 23.3 0.49  0.07 0.46  0.02 28.1 22.6 40.7 1.3 0.19 0.78 0.36 
a
 m1: first microstate (most-populated); 
b
 M: Macrostate; 
c
 Basin definitions are, : 
 L/D φ= –/+ 20 to –/+ 100, L/D = –/+ 20 to –/+ 80; :  L/D 
φ= –/+ 90 to –/+ 170, L/D = +/– 80 to +/– 180; PPII:  L/D φ= –/+ 30 to –/+ 90, L/D = +/– 80 to +/– 170; d The total number of hydrogen 
bonds during the entire simulation divided by the total number of conformations sampled during simulation is defined as average number of 
hydrogen bonds per conformation (Avg./Conf.);  
e
 Hydrogen bonds are short-ranged (SR; i→i ± 2), medium-ranged (MR; i→i ± 3, i→i ± 4) 
and long-ranged (LR; i→i ± 5,  i→i ±  6) according to sequence separation between donor and acceptor residue.  
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The equilibria were analyzed on basis of radius-of-gyration (Rg) over polypeptide structure to 
highlight the state of “folding” or “unfolding”.  The results depicted in Figure 2 manifest 
“folding” to a bent conformation involving close spatial proximity between N- and C-termini 
in the model peptides.  
 
Figure 2. The central member of two most-populated microstates (m1 and m2) of end-protected cationic 
peptides, Ia and IIa (upper panel) and ion-pair peptides, Ib and IIb (lower panel) are shown in the stick 
representation. The hydrogen bonds among NH, C=O groups are shown in purple dashed lines. The percent 
population of each microstate is shown in parenthesis. 
From the statistics of basin occupancy reported in Table 2, the model peptides have 
occupancy in ,  and PPII basins which highlight that model peptides adopt multiple 
conformations in water. These results are consistent with those previously reported by 
Dalgicdir et al. which highlight that two synthetic peptides, LKKLLKLLKKLLKL (LK) and 
EAALAEALAEALAE (EALA), adopt neither random coil nor fully formed -helical 





 Using molecular dynamics simulations, the authors reported that the 
peptides adopt multiple conformations with short lifetimes in water.
 [27]
 
As noted from Table 2, the occupancy of  basin is much higher for ion-pair peptides as 
compare to cationic peptides. The occupancy in  basin is 28.5%, 28.1% for Ib, IIb, 
respectively, while the occupancy is only 19.2%, 19.9% for Ia, IIa, respectively. The φ 
spread and preferential basin occupancies of macrostate over end-protected cationic peptides, 
Ia, IIa and ion-pair peptides, Ib, IIb during molecular dynamics simulation is shown in 
Figure 3. As depicted in Figure 3, the occupancy of  basin is much higher for ion-pair 
peptides than cationic peptides. Correspondingly, the occupancy in PPII basin decrease from 
44.3%, 45.1% for Ia, IIa, respectively, to 39.2%, 40.7% for Ib, IIb, respectively (Table 2).  
We have not observed a significant change in the occupancies of and PP-basin in the 





Pro) which is consistent with the results from the previous 
study.
[13b]

















Ala-NHMe, sample identical 
structures in the conformational ensemble.
[13b]
 These results are consistent with the results 
reported by M. Oba et al.
[28]
 The authors have investigated the solid-state conformation of 
diastereomeric -Pro-Pro-(Aib)4 sequences. The authors have attached the two diastereomeric 
diproline (L-Pro-L-Pro and D-Pro-L-Pro) segments on the N-terminus of H-(Aib)4-OMe 
segment. X-ray crystallographic analysis highlighted that the two diastereomeric 
hexapeptides, Cbz-L-Pro-L-Pro-(Aib)4-OMe (1) and Cbz-D-Pro-L-Pro-(Aib)4-OMe (2), 
formed identical structures with different N-terminal Pro residues. 




Figure 3. The φ spread and preferential basin occupancies of macrostates over end-protected cationic 
peptides, Ia and IIa (upper panel) and ion-pair peptides, Ib and IIb (lower panel) during molecular dynamics 
simulation. 
Correlated with higher occupancy of  conformation for ion-pair peptides, a higher average 
number of MR hydrogen bonds are observed for ion-pair peptides as compare to cationic 
peptides. The average number of MR hydrogen bonds increased from 0.46, 0.53 for Ia, IIa, 
repectively, to 0.70, 0.78 for Ib, IIb, respectively. The total number of hydrogen bonds 
during the entire simulation divided by the total number of conformations sampled during 
simulation have been evaluated for each ensemble and we defined it as average number of 
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hydrogen bonds per conformation (Avg./Conf.). As listed in Table 2, the average number of 
hydrogen bonds per conformation are higher for ion-pair peptides as compare to cationic 
peptides which indicate more folded conformations were sampled for ion-pair peptides. Thus, 
a combined effect of N-terminal diproline of homochiral, heterochiral structure and large side 
chain substituents of lysine and glutamic acid residues in the i, i + 4 arrangement in ion-pair 
peptides, Ib and IIb, promote higher occupancy of the macrostate in the  basin. 
To analyze the influence of N-terminal diproline of homochiral and heterochiral structure, 
cationic lysine side chains, and large side chain substituents of lysine and glutamic acid 
residues in the i, i + 4 arrangement, we resolve the canonical ensembles to the microstates. 
The stick representation of two most-populated microstates, m1 and m2, with percent 
population in parenthesis is shown in Figure 2. As depicted in Figure 2, the microstates of 
peptides Ia, Ib, IIa, IIb adopt a U-shape conformation in water, apparently maximized in 
intrachain interaction involving short, medium and long ranged hydrogen bonds of peptides, 
viz. SR, MR, and LR hydrogen bonds. Thus, according to molecular dynamics, the model 
peptides exist in the bent-shaped conformational folds in water apparently maximized in 
intrachain interaction. The ion-pair peptide Ib with large side chain substituents of lysine and 
glutamic acid residues in the i, i + 4 arrangement has the partially folded helical structure in 
water as observed in the second microstate (Figure 2).  
Solvation shell analysis 
To elucidate the effect of solvent on the conformation of model peptides, we calculated the 
radial distribution function (RDF) of solvent atoms against atoms of the model peptides. The 
calculated RDF of oxygen atom of solvent water around N, O, Nζ (lysine), C (alanine), and 
O (glutamic acid) atoms of the model peptides are shown in Figure 4 and 5. The absence of 
first RDF maxima of oxygen atom of water against peptide-NH in the cationic as well as ion-
This article is protected by copyright. All rights reserved 
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pair peptides suggest the involvement of peptide-NH groups in intrapeptide hydrogen 
bonding (Figure 4 and 5). Thus, the model peptides adopt U-shapedconformation in water 
which is also reflected in stick representation of the conformational folds of two most-
populated microstates shown in Figure 2. 
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Figure 4. Radial distribution of oxygen atom of solvent water against N, O, Nζ (lysine), and C (alanine) atoms 
of the most-populated microstate of cationic peptides, Ia (left panel) and IIa (right panel).  
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Figure 5. Radial distribution of oxygen atom of solvent water against N, O, Nζ (lysine), C (alanine), and O 
(glutamic acid) atoms of the most-populated microstate of ion-pair peptides, Ib (left panel) and IIb (right panel). 
The C atom of alanine has first RDF maxima at 0.36 nm against oxygen of water which 
suggest methyl group of alanine may be solvated by combination of C-H…O hydrogen bonds 
and van der Waals (vdW) interactions. As depicted in Figure 4 and 5, Nζatomof lysine has 
first RDF maxima at 0.30 nm against oxygen of water in cationic as well as ion-pair peptides 
that suggest solvation of the lysine side chain through hydrogen bonding with water. The O 
atomof glutamic acid has first RDF maxima at 0.30 nm against oxygen of water in ion-pair 
peptides that suggest solvation through hydrogen bonding with water (Figure 5). The RDF 
analysis highlight that charged side chains of the lysine and glutamic acid residues are 
solvated by water molecules. This imply that the large side chain substituents of lysine and 
glutamic acid residues assist in helix formation by blocking water molecules from solvating 
backbone CO and NH groups as observed in the formation of partially folded helical structure 
in the ion-pair peptide, Ib, which is in agreement with the earlier reports.
[2d,2e,29,30]
 
It is reported in literature that short (n = 10) sequences of Ala peptides, Alan, do not form 
helices in water.
[31]
 The NMR data for short polyalanine peptides, (Ala3−7), highlighted that 
the peptides exist as polyproline II (PPII) helix-like structures with very little population in 
the α-helical conformation.
[32]
 In the present study, MD simulations highlight inducement of 
helical conformation in a short alanine-based peptides by employing N-terminal diproline 
segment and lysine, glutamic acid residues in the i, i + 4 arrangement which is significant for 
a peptide of nine-residue length. The results of the present study will expand our 
understanding of peptide and protein folding, and will aid in the design of novel peptides with 
-helical structures which can modulate PPIs. 
 




In the present study, we have examined the effect of N-terminal diproline segment and 
charged side chains in the alanine-based short peptides as an approach to scrutinize the 
specific role of interactions within main chain and between side chains on the inducement of 
helical conformation. MD simulations reveal enhanced occupancies in the  basin of φψ 
space for ion-pair peptides, Ib and IIb, as compare to cationic peptides, Ia and IIa, while the 
occupancies are nearly identical whether the N-terminal diproline segment is homochiral or 
heterochiral in structure. Thus, MD simulations highlight sampling of the -conformation in 
the model peptides largely depend on the large side chain substituents of lysine and glutamic 
acid residues in the i, i + 4 arrangement rather than stereochemical structure of the N-terminal 
diproline segment. The RDF analysis highlight that charged side chains of lysine and 
glutamic acid residues are solvated by water molecules which imply that large side chain 
substituents of lysine and glutamic acid residues assist in helix formation, although partially 
folded, by blocking water molecules from solvating backbone CO and NH groups. MD 
simulations highlight the influence of N-terminal diproline segment as well as large side 
chain substituents of lysine and glutamic acid residues in the i, i + 4 arrangement on the 
inducement of helical conformation in alanine-based short peptides. The present study will 
enhance our understanding on nucleation of helical conformation in short peptides and hence 
aid in the design of novel peptides with helical structures. 
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Pro, and large side chain substituents of 
lysine and glutamic acid residues in the i, i + 4 arrangement stabilize the helical conformation 
in alanine-based nonapeptide, Ac–Pro1–Pro2–Glu3–Glu4–Ala5–Ala6–Lys7–Lys8–Ala9–NH2 
(Ib), as observed in the second most-populated microstate, m2, during molecular dynamics in 
explicit-water. 
 
  
 
